Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Return to: PBR Home | Drug Research
Today in Drug Research

Drug Research

AstraZeneca invests another $140m in Moderna Therapeutics AstraZeneca has invested another $140m in Moderna Therapeutics, a US-based biotechnology company focused on the research and development of protein therapies based on novel messenger RNA (mRNA) technology. Drug Research > Drug Discovery & Development > News

Latest Drug Research News by Sector

Select a sector from the list or browse by sector below:

Drug Delivery

Impax recalls one lot of Lamotrigine Orally Disintegrating Tablet 200 mg
Impax Laboratories has issued a voluntary nationwide retail level recall on August 19, 2016 for one lot of Lamotrigine Orally Disintegrating Tablet (ODT) 200 mg.
Drug Research > Drug Delivery > News
Marken secures new pharmaceutical license for Moscow depot
Marken has secured a new pharmaceutical license from the Russian Federation for its Moscow depot.
Drug Research > Drug Delivery > News

Drug Discovery & Development

BioLineRx and I-Bridge Capital establish drug development JV in China
BioLineRx has established a joint venture (JV) with I-Bridge Capital, a Chinese venture capital fund focused on developing innovative therapies in China.
Drug Research > Drug Discovery & Development > News
F-star, Denali Therapeutics partner to develop multispecific antibody platform
By PBR Staff Writer
UK-based biopharmaceutical firm F-star has signed a collaborative agreement with the US start-up Denali Therapeutics to develop a multispecific antibody platform for delivering therapeutics across the blood-brain barrier into the central nervous system (CNS).
Drug Research > Drug Discovery & Development > News